Share on StockTwits

Analysts at Argus raised their price target on shares of CVS Caremark (NYSE:CVS) from $83.00 to $85.00 in a research report issued to clients and investors on Wednesday. The firm currently has a “buy” rating on the stock. Argus’ price target points to a potential upside of 10.35% from the company’s current price.

A number of other firms have also recently commented on CVS. Analysts at RBC Capital raised their price target on shares of CVS Caremark from $76.00 to $86.00 in a research note on Wednesday. They now have an “outperform” rating on the stock. Separately, analysts at Mizuho raised their price target on shares of CVS Caremark from $81.00 to $85.00 in a research note on Wednesday. They now have a “buy” rating on the stock. Finally, analysts at Cowen and Company raised their price target on shares of CVS Caremark from $80.00 to $85.00 in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. CVS Caremark has a consensus rating of “Buy” and an average target price of $80.48.

CVS Caremark (NYSE:CVS) traded down 0.31% during mid-day trading on Wednesday, hitting $77.03. 11,306,821 shares of the company’s stock traded hands. CVS Caremark has a 52 week low of $56.32 and a 52 week high of $79.43. The stock has a 50-day moving average of $76.92 and a 200-day moving average of $74.25. The company has a market cap of $90.356 billion and a P/E ratio of 19.68. CVS Caremark also was the recipient of unusually large options trading on Monday. Traders bought 7,359 put options on the company. This represents an increase of approximately 776% compared to the typical daily volume of 840 put options.

CVS Caremark (NYSE:CVS) last released its earnings data on Tuesday, August 5th. The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter in the previous year, the company posted $0.97 earnings per share. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. On average, analysts predict that CVS Caremark will post $4.47 earnings per share for the current fiscal year.

CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.